| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 5, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 5, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Save time and jump to the most important pieces.
SC 13D/A - DSS, INC. (0000771999) (Filed by)
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Subject)
4 - DSS, INC. (0000771999) (Issuer)
4 - DSS, INC. (0000771999) (Issuer)
3 - DSS, INC. (0000771999) (Issuer)
Gainers Royalty Management Hldgs (NASDAQ:RMCO) stock increased by 6.1% to $1.92 during Wednesday's after-market session. The company's market cap stands at $27.3 million. Mesa Air Gr (NASDAQ:MESA) shares moved upwards by 4.99% to $0.93. The company's market cap stands at $38.1 million. View (NASDAQ:VIEW) shares increased by 4.98% to $3.16. The market value of their outstanding shares is at $12.8 million. Nxu (NASDAQ:NXU) stock increased by 4.43% to $1.84. The market value of their outstanding shares is at $3.2 million. DSS (AMEX:DSS) shares moved upwards by 4.34% to $0.12. The market value of their outstanding shares is at $16.8 million. ARC Document Solutions (NYSE:ARC) shares increas
10-Q - DSS, INC. (0000771999) (Filer)
EFFECT - DSS, INC. (0000771999) (Filer)
S-3/A - DSS, INC. (0000771999) (Filer)
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company's growth. Chairman Chan acquired an additional 672,173 shares of DS, Inc. in an open market transaction on December 28, 2023. Frank Heuszel, CEO of DSS, Inc., expressed his enthusiasm for Mr. Chan's increased stake, viewing it as a strong vote of confidence in the company's strategic direction and future potential. Heuszel said, "Chairman Chan's decis
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the "Reverse Split") of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to effect a reverse split by a ratio of not less than 1-for-20 and not more than 1-for-40 (the "Reverse Split Range"), at any time on or before April 20, 2024, with the Board having the discre
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12 Million with a fourth year extension option bringing the potential total revenue to over $15 Million. Frank D. Heuszel, President and CEO of DSS, Inc., said, "We are very pleased to see that our capital investment to increase production capacity and economies of scale at
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE:IBO), is delighted to announce the successful pricing of Impact BioMedical's initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness solutions, has set its IPO price at $3.00 per share, with an initial offering of 1,500,000 shares. Trading under the ticker symbol "IBO," these shares will begin trading on the NYSE American Market on September 16, 2024. This significant achievement underscores Impact BioMedical's innovative contributions to the healthcare sector and represents a major milestone for DSS. We ar
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE:DSS), today announced that effective August 9, 2024, David Friedensohn, Monica Himes and Allan Siegel have resigned from their positions as independent directors. The Trust is pleased to announce the election of three new independent directors by shareholder proxy vote: Dr. Prabir Datta, Darryl Robinson and Mark Gronet. These individuals are seasoned senior investment executives who bring a wealth of experience and expertise in asset management, risk management, investment operations and sales. "We are appreciative for the service and commitment by our outgoing directors," said Daniel
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as Chief Operating Officer of DSS, Inc., brings over 25 years of extensive experience in executive leadership, business development, restructuring, and operations management across a variety of industries. He will succeed Frank D. Heuszel, who is exiting the company to transition to a leadership role within one of its former subsidiaries. Throughout his career, Mr. Grady has held pivotal positions within DSS, including CEO and Director of DSS Biohealth Holdings, President of Premier Packaging Corporation,
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as Chief Operating Officer of DSS, Inc., brings over 25 years of extensive experience in executive leadership, business development, restructuring, and operations management across a variety of industries. He will succeed Frank D. Heuszel, who is exiting the company to transition to a leadership role within one of its former subsidiaries. Throughout his career, Mr. Grady has held pivotal positions within DSS, including CEO and Director of DSS Biohealth Holdings, President of Premier Packaging Corporation,
ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as Chief Investment Officer and Portfolio Manager. With over three decades of experience in investment management, security analysis, and institutional client advisory, Mr. Lew brings a wealth of knowledge and expertise to his new role. Mr. Lew's distinguished career spans various prestigious financial institutions, where he has held senior investment management positions. Prior to joining DSS Wealth, Inc., he served as a key contributor at AIG SunAmerica, Strong Capital, John Hs
ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced the expansion of its Board of Directors with the appointment of two independent directors, Frankie Wong, a 20-year veteran of public-company financial reporting, and Joanne Wong Hiu Pan, an investment manager with BMI Funds Management Ltd., the leading financial advisor in Hong Kong. Mr. Wong is a certified public accountant in Hong Kong with more than 20 years' practici